Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Nu-Med Plus (NUMD) Return on Capital Employed (2016 - 2021)

Nu-Med Plus' Return on Capital Employed history spans 9 years, with the latest figure at 24.14% for Q3 2021.

  • Quarterly results put Return on Capital Employed at 24.14% for Q3 2021, up 2929.0% from a year ago — trailing twelve months through Sep 2021 was 24.14% (up 2929.0% YoY), and the annual figure for FY2020 was 9.07%, down 1468.0%.
  • Return on Capital Employed for Q3 2021 was 24.14% at Nu-Med Plus, up from 16.24% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 123.78% in Q1 2018 to a low of 141.29% in Q2 2018.
  • The 5-year median for Return on Capital Employed is 0.02% (2017), against an average of 3.16%.
  • The sharpest move saw Return on Capital Employed crashed -14035bps in 2018, then soared 14732bps in 2019.
  • Year by year, Return on Capital Employed stood at 34.02% in 2017, then tumbled by -131bps to 10.5% in 2018, then soared by 128bps to 2.9% in 2019, then tumbled by -233bps to 3.85% in 2020, then surged by 727bps to 24.14% in 2021.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 24.14%, 16.24%, and 6.6% for Q3 2021, Q2 2021, and Q1 2021 respectively.